US 12030869
5-membered heteroaryl carboxamide compounds for treatment of HBV
granted A61PA61P31/12A61P31/20
Quick answer
US patent 12030869 (5-membered heteroaryl carboxamide compounds for treatment of HBV) held by ASSEMBLY BIOSCIENCES, INC. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ASSEMBLY BIOSCIENCES, INC.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P31/12, A61P31/20